Director Hideki Garren resigns from Coya board effective Nov 1, 2024

Coya Therapeutics, Inc.

Dr. Hideki Garren resigned immediately to comply with new employer's policy barring board service on companies with similar therapeutic areas.
Resignation was not due to any disagreement with Coya or its management on operations, policies, or practices.
Board seat vacancy created; no replacement announced as of filing date.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Hideki Garren

Director

COYA · Coya Therapeutics, Inc.

Effective: 2024-11-01
Filed: November 5, 2024, 6:59 PM ET

On November 1, 2024, Dr. Hideki Garren provided Coya Therapeutics, Inc. (the “Company”) with notice of his resignation from the Board of Directors, effective immediately.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Hideki Garren resigned as Director at Coya Therapeutics, Inc..

Action: resigned
Role: Director

Exact text from the filing

On November 1, 2024, Dr. Hideki Garren provided Coya Therapeutics, Inc. (the “Company”) with notice of his resignation from the Board of Directors, effective immediately.

View on SEC.gov

Coya Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001193125-24-251319

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.